This analysis identifies increasing compositional uniqueness of the gut microbiome as a component of healthy ageing, which is characterized by distinct microbial metabolic outputs in the blood.
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults
Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults SARS-CoV-2 is the cause of COVID-19.
New multivariable prediction model for distinguishing subjects with chronic pancreatitis from control subjects with diseases other than pancreatic disease
Chronic pancreatitis (CP) is a fibroinflammatory syndrome leading to organ dysfunction, chronic pain, an increased risk for pancreatic cancer and considerable morbidity.
The microbiota in the human body has a symbiotic relationship with the human body and plays an important role in cancer treatment.
The microbiota can contribute to both progression and suppression of the disease, including cancer.
Microbial dysbiosis has been implicated in the pathogenesis of oral cancer. We analyzed the compositional and metabolic profile of the bacteriome in three specific niches in oral cancer patients along with controls using 16SrRNA sequencing (Illumina Miseq) and DADA2 software.
Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice
The gut microbiome can influence the development of tumors and the efficacy of cancer therapeutics; however, the multiomics characteristics of antitumor bacterial strains have not been fully elucidated.
This work describes a new procedure that allows the targeted modification of the human gut microbiota by using antibodies raised against bacterial surface-associated proteins specific to the microorganism of interest.
An increased risk of developing colorectal cancer (CRC) and other types of tumor is associated to Lynch syndrome (LS), an inherited condition caused by germline mutations in mismatch repair genes.